(NYSEMKT: AZTR) Azitra's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.19%.
Azitra's earnings in 2026 is -$12,272,932.On average, 4 Wall Street analysts forecast AZTR's earnings for 2026 to be -$10,817,768, with the lowest AZTR earnings forecast at -$16,035,750, and the highest AZTR earnings forecast at -$5,090,714. On average, 4 Wall Street analysts forecast AZTR's earnings for 2027 to be -$19,781,061, with the lowest AZTR earnings forecast at -$32,665,417, and the highest AZTR earnings forecast at -$5,727,054.
In 2027, AZTR is forecast to generate -$6,490,661 in earnings, with the lowest earnings forecast at -$7,720,917 and the highest earnings forecast at -$5,090,714.